Definition
Delta‑sarcoglycan is a single‑pass transmembrane glycoprotein that forms part of the sarcoglycan complex, a sub‑assembly of the dystrophin‑associated glycoprotein (DAP) complex in skeletal and cardiac muscle cells. In humans it is encoded by the SGCD gene.
Overview
The sarcoglycan complex comprises four core subunits—α‑, β‑, γ‑, and δ‑sarcoglycan—and, in some tissues, additional members such as ε‑ and ζ‑sarcoglycan. Together with dystrophin and associated proteins, the complex links the intracellular actin cytoskeleton to the extracellular matrix, thereby stabilizing the muscle cell membrane (sarcolemma) during contraction. Loss‑of‑function mutations in SGCD cause autosomal recessive limb‑girdle muscular dystrophy type 2F (LGMD2F) and are also implicated in certain forms of hereditary cardiomyopathy. Delta‑sarcoglycan is expressed predominantly in skeletal muscle, with detectable levels in cardiac muscle and, to a lesser extent, smooth muscle.
Etymology/Origin
The name combines the Greek letter “delta” (Δ), used in the sarcoglycan family to designate this particular isoform, with “sarcoglycan,” itself derived from “sarco‑” (Greek σάρξ, “flesh” or “muscle”) and “glycan” (from “glycoconjugate,” indicating a protein bearing carbohydrate groups). The designation therefore denotes the “delta” member of the muscle‑associated glycoprotein family.
Characteristics
| Feature | Description |
|---|---|
| Gene | SGCD located on chromosome 5q33.2 |
| Protein length | 290 amino acids (human isoform) |
| Molecular mass | Approximately 35 kDa (post‑translationally glycosylated) |
| Domain structure | N‑terminal extracellular region rich in O‑linked glycans, a single transmembrane helix, and a short cytoplasmic C‑terminal tail |
| Complex formation | Heterodimerizes with β‑ and γ‑sarcoglycan; the tetrameric α/β/γ/δ complex integrates into the DAP complex |
| Cellular localization | Sarcolemma of skeletal and cardiac muscle fibers |
| Biological role | Contributes to mechanical stability of muscle fibers, participates in signaling pathways that regulate membrane repair and calcium homeostasis |
| Pathology linked to mutations | Autosomal recessive LGMD type 2F; dilated cardiomyopathy; occasional isolated cardiac phenotypes |
| Animal models | Sgcd‑deficient mouse models display progressive muscular dystrophy and cardiac dysfunction, corroborating the human disease phenotype |
Related Topics
- Sarcoglycan complex (α‑, β‑, γ‑, δ‑sarcoglycan)
- Dystrophin‑associated glycoprotein (DAP) complex
- Limb‑girdle muscular dystrophy (LGMD) – especially type 2F
- SGCA, SGCB, SGCG, SGCE – genes encoding other sarcoglycan isoforms
- Dystrophin gene (DMD) and Duchenne/Becker muscular dystrophies
- Cardiomyopathy, particularly dilated forms associated with sarcoglycan deficiencies
- Muscular dystrophy research and therapeutic approaches (e.g., gene therapy, exon skipping)
All information presented reflects current scientific consensus as of the latest peer‑reviewed literature.